DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Clinical trials for DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to shrink tumors before surgery in Hard-to-Treat rectal cancer

Disease control Ongoing

This study is testing whether giving two immunotherapy drugs (iparomlimab and tuvonralimab) before surgery can help shrink or eliminate tumors in patients with a specific type of locally advanced rectal cancer. The main goal is to see if the treatment leads to a 'pathologic compl…

Matched conditions: DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Get alerted when new DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA trials appear

New drug combo aims to shrink tumors before surgery in Hard-to-Treat rectal cancer